Abstract
Erlotinib 10 mg/mL in Ora-Sweet and Ora-Plus
Author(s): Allen Loyd V Jr
Issue: Jan/Feb 2023 - Volume 27, Number 1
Page(s): 53
Download in electronic PDF format for $75
Abstract
A formulation for preparing Erlotinib 10 mg/mL in Ora-Sweet and Ora-Plus. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.
Related Keywords
- erlotinib
- formulations
- oral suspensions
- antineoplastic agent
- epidermal growth factor receptor inhibitor
- EGF receptor blocker
- anticancer agent
- cancer
- tumor
Related Categories
- CANCER AND AIDS
- EXCIPIENTS
- FORMULATIONS
- DOSAGE FORMS/DRUG CARRIERS